Home » Topics » BioWorld Science

BioWorld Science
RSS

Novartis enters license option agreement with Voyager for AAV capsids for gene therapy programs

March 8, 2022

Study finds variants that increase risk of severe COVID-19

March 8, 2022

METTL3 inhibition with STM-2457 leads to antitumor effects in OSCC

March 8, 2022

LABP-73 demonstrates efficacy in preclinical models of chronic asthma

March 8, 2022

BMAL1 disruption has an impact on metabolic and liver disease

March 8, 2022

Nanoengineered Bifidobacterium bifidum suppresses tumors in vivo

March 8, 2022

VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model

March 7, 2022

Modulation of RICTOR/mTORC2 axis is an approach for sensorineural hearing loss

March 7, 2022

Regulation of BIN1 ameliorates dynamin-related myopathy

March 7, 2022

Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells

March 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...